PL326636A1 - Derivatives of quinoline as inhibitors of type iv phosphodiesterase - Google Patents
Derivatives of quinoline as inhibitors of type iv phosphodiesteraseInfo
- Publication number
- PL326636A1 PL326636A1 PL96326636A PL32663696A PL326636A1 PL 326636 A1 PL326636 A1 PL 326636A1 PL 96326636 A PL96326636 A PL 96326636A PL 32663696 A PL32663696 A PL 32663696A PL 326636 A1 PL326636 A1 PL 326636A1
- Authority
- PL
- Poland
- Prior art keywords
- phosphodiesterase
- quinoline
- inhibitors
- derivatives
- type
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9523267.4A GB9523267D0 (en) | 1995-11-14 | 1995-11-14 | Organic compounds |
| PCT/EP1996/004978 WO1997018208A1 (en) | 1995-11-14 | 1996-11-13 | Quinoline derivatives as type iv phosphodiesterase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL326636A1 true PL326636A1 (en) | 1998-10-12 |
Family
ID=10783856
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL96326636A PL326636A1 (en) | 1995-11-14 | 1996-11-13 | Derivatives of quinoline as inhibitors of type iv phosphodiesterase |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0873338A1 (en) |
| JP (1) | JPH11515000A (en) |
| KR (1) | KR19990067574A (en) |
| CN (1) | CN1202170A (en) |
| AU (1) | AU7570996A (en) |
| BR (1) | BR9611504A (en) |
| CA (1) | CA2235126A1 (en) |
| CO (1) | CO4770973A1 (en) |
| CZ (1) | CZ149498A3 (en) |
| GB (1) | GB9523267D0 (en) |
| HU (1) | HUP9903492A3 (en) |
| MX (1) | MX9803839A (en) |
| PE (1) | PE17598A1 (en) |
| PL (1) | PL326636A1 (en) |
| SK (1) | SK63998A3 (en) |
| TR (1) | TR199800851T2 (en) |
| WO (1) | WO1997018208A1 (en) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1212089T1 (en) | 1999-08-21 | 2006-08-31 | Altana Pharma Ag | Synergistic combination of roflumilast and salmeterol |
| US20040180900A1 (en) | 2001-05-23 | 2004-09-16 | Masaharu Takigawa | Therapeutic composition for repairing chondropathy |
| MXPA03010679A (en) | 2001-05-23 | 2004-03-02 | Tanabe Seiyaku Co | Compositions for promoting healing of bone fracture. |
| TW200536851A (en) | 2004-01-23 | 2005-11-16 | Amgen Inc | Compounds and methods of use |
| JP2006347936A (en) * | 2005-06-15 | 2006-12-28 | Bayer Cropscience Ag | Insecticidal benzanilides |
| WO2011143106A1 (en) | 2010-05-10 | 2011-11-17 | Gilead Sciences, Inc. | Bi - functional pyrazolopyridine compounds |
| JP5807058B2 (en) | 2010-05-10 | 2015-11-10 | ギリアード サイエンシーズ， インコーポレイテッド | Bifunctional quinoline derivative |
| BR112015008515A2 (en) | 2012-10-16 | 2017-07-04 | Janssen Pharmaceutica Nv | heteroaryl-linked quinolinyl ror t modulators |
| PT2909192T (en) | 2012-10-16 | 2017-08-04 | Janssen Pharmaceutica Nv | Methylene linked quinolinyl modulators of ror-gamma-t |
| EA201590750A1 (en) | 2012-10-16 | 2015-09-30 | Янссен Фармацевтика Нв | RELATED QUINOLINYL MODULATORS WITH PHENYL |
| US10555941B2 (en) | 2013-10-15 | 2020-02-11 | Janssen Pharmaceutica Nv | Alkyl linked quinolinyl modulators of RORγt |
| US9403816B2 (en) | 2013-10-15 | 2016-08-02 | Janssen Pharmaceutica Nv | Phenyl linked quinolinyl modulators of RORγt |
| EP3057422B1 (en) | 2013-10-15 | 2019-05-15 | Janssen Pharmaceutica NV | Quinolinyl modulators of ror(gamma)t |
| US9284308B2 (en) | 2013-10-15 | 2016-03-15 | Janssen Pharmaceutica Nv | Methylene linked quinolinyl modulators of RORγt |
| US9221804B2 (en) | 2013-10-15 | 2015-12-29 | Janssen Pharmaceutica Nv | Secondary alcohol quinolinyl modulators of RORγt |
| US9328095B2 (en) | 2013-10-15 | 2016-05-03 | Janssen Pharmaceutica Nv | Heteroaryl linked quinolinyl modulators of RORgammat |
| AU2014334619A1 (en) | 2013-10-15 | 2016-04-21 | Janssen Pharmaceutica Nv | Alkyl linked quinolinyl modulators of RORyt |
| IL279410B2 (en) * | 2018-06-24 | 2024-03-01 | Adama Agan Ltd | Process for the preparation of quinmerac |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9027055D0 (en) * | 1990-12-13 | 1991-02-06 | Sandoz Ltd | Organic compounds |
| US5455252A (en) * | 1993-03-31 | 1995-10-03 | Syntex (U.S.A.) Inc. | Optionally substituted 6,8-quinolines |
-
1995
- 1995-11-14 GB GBGB9523267.4A patent/GB9523267D0/en active Pending
-
1996
- 1996-11-12 PE PE1996000810A patent/PE17598A1/en not_active Application Discontinuation
- 1996-11-13 EP EP96938196A patent/EP0873338A1/en not_active Withdrawn
- 1996-11-13 CZ CZ981494A patent/CZ149498A3/en unknown
- 1996-11-13 BR BR9611504A patent/BR9611504A/en not_active Application Discontinuation
- 1996-11-13 CN CN96198305A patent/CN1202170A/en active Pending
- 1996-11-13 HU HU9903492A patent/HUP9903492A3/en unknown
- 1996-11-13 CA CA002235126A patent/CA2235126A1/en not_active Abandoned
- 1996-11-13 JP JP9515313A patent/JPH11515000A/en not_active Withdrawn
- 1996-11-13 KR KR1019980703597A patent/KR19990067574A/en not_active Application Discontinuation
- 1996-11-13 CO CO96059775A patent/CO4770973A1/en unknown
- 1996-11-13 PL PL96326636A patent/PL326636A1/en unknown
- 1996-11-13 SK SK639-98A patent/SK63998A3/en unknown
- 1996-11-13 WO PCT/EP1996/004978 patent/WO1997018208A1/en not_active Application Discontinuation
- 1996-11-13 AU AU75709/96A patent/AU7570996A/en not_active Abandoned
- 1996-11-13 TR TR1998/00851T patent/TR199800851T2/en unknown
-
1998
- 1998-05-14 MX MX9803839A patent/MX9803839A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB9523267D0 (en) | 1996-01-17 |
| JPH11515000A (en) | 1999-12-21 |
| TR199800851T2 (en) | 1998-08-21 |
| CA2235126A1 (en) | 1997-05-22 |
| EP0873338A1 (en) | 1998-10-28 |
| PE17598A1 (en) | 1998-04-06 |
| CO4770973A1 (en) | 1999-04-30 |
| HUP9903492A3 (en) | 2000-08-28 |
| SK63998A3 (en) | 1998-10-07 |
| CZ149498A3 (en) | 1998-08-12 |
| KR19990067574A (en) | 1999-08-25 |
| HUP9903492A2 (en) | 2000-07-28 |
| CN1202170A (en) | 1998-12-16 |
| AU7570996A (en) | 1997-06-05 |
| BR9611504A (en) | 1999-03-02 |
| MX9803839A (en) | 1998-09-30 |
| WO1997018208A1 (en) | 1997-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL327185A1 (en) | Thyrosine derivatives as inhibitors of integrin-alpha v | |
| PL333918A1 (en) | Derivatives of 6-phenylpyryidil-2-amine useful as nos inhibitors | |
| PL326967A1 (en) | Quinoline derivatives | |
| PL326636A1 (en) | Derivatives of quinoline as inhibitors of type iv phosphodiesterase | |
| PL324819A1 (en) | Derivatives of 4-mercaptopyrrolidine as inhibitors of farnesil transferase | |
| PL327569A1 (en) | Promedications of thrombosin inhibitors | |
| AU6419296A (en) | Cyclic gmp-specific phosphodiesterase inhibitors | |
| PL313541A1 (en) | Derivatives of quinazoline | |
| PL323066A1 (en) | Derivatives of quinazoline | |
| IL135673A0 (en) | Therapeutic uses of quinoline derivatives | |
| PL331856A1 (en) | Heterocyclic inhibitors of metaloprotease | |
| IL141445A0 (en) | Benzazine derivatives as phosphodiesterase 4 inhibitors | |
| AU7168696A (en) | Inhibitors of regulatory pathways | |
| GB9603723D0 (en) | Diphenyl pyridyl derivatives as pde iv inhibitors | |
| AU4756696A (en) | Compounds for and method of inhibiting phosphodiesterase iv | |
| PL324106A1 (en) | Derivatives of benzo [g] quinoline | |
| AU3039995A (en) | Heterocyclic derivatives of N-phenylamides | |
| AU2274299A (en) | Benzazine derivatives phosphodiesterase 4 inhibitors | |
| PL329153A1 (en) | Derivatives of pyrrolopyrolone as inhibitors of neutropil elastase | |
| PL325122A1 (en) | Bicyclic derivatives of 4-aralkylamino pyrididine as inhibitors of thyrosinic kinase | |
| PL324034A1 (en) | Tribenzimidazoles useful as inhibitors of topoisomerase i | |
| PL326927A1 (en) | Salts of quinolin derivatives as nk3 antagones | |
| IL141446A0 (en) | Benzazine derivatives as phosphodiesterase 4 inhibitors | |
| AU3075595A (en) | Anti-helicobacter heterocyclic derivatives of azolones | |
| AP2000001767A0 (en) | Method for synthesis of quinoline derivatives |